AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BOTANIX PHARMACEUTICALS LTD

0.020

0.000

Volume:25.65M

Turnover:491.73K

Market Cap:54.69M

PE:-0.43

High:0.020

Open:0.019

Low:0.018

Close:0.020

52wk High:0.350

52wk Low:0.018

Shares:2.73B

Float Shares:1.72B

Volume Ratio:2.21

T/O Rate:1.49%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.046

EPS(LYR):-0.047

ROE:-121.11%

ROA:-53.38%

PB:1.01

PE(LYR):-0.43

Loading ...

Overview Company News Filings

Thailand's Foreign Reserves Rise in May

MT Newswires Live

BLUE OCEAN TECHNOLOGIES APPOINTS WILLIAM GOODBODY, JR. AS HEAD OF MARKET OPERATIONS FOR BLUE OCEAN ATS IN AUSTRALIA

Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development

Botanix Pharmaceuticals Appoints Chief Operating Officer; Shares Fall 4%

MT Newswires Live

Botanix Pharmaceuticals Ltd - Appoints Paul Seaback as Chief Operating Officer

THOMSON REUTERS

Botanix Pharmaceuticals Ltd-Botanix Appoints Chief Operating Officer

THOMSON REUTERS

Botanix Pharmaceuticals' Q3 Results Beat Estimates, Says Euroz Hartleys

MT Newswires Live

Botanix Pharmaceuticals Ltd-Botanix Q3 FY26 Investor Update Webinar Presentation

THOMSON REUTERS

BRIEF-Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier

BUZZ-Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions

Botanix Pharmaceuticals - Piramal to Commence Development Services , Serve as Alternate Commercial Supplier of Sofpironium Bromide, API in Sofdra

THOMSON REUTERS

Botanix Pharmaceuticals Defers API Purchases to 2027, 2028 Under Amended Supply Agreement

MT Newswires Live

Botanix Pharmaceuticals' Axillary Hyperhidrosis Product Outsells Competing Product, Says Euroz Hartleys

MT Newswires Live

BRIEF-Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million

Botanix Pharmaceuticals Ltd - Revenue From Ordinary Activities for Hy a$16.5 Mln

THOMSON REUTERS

Bank of Thailand Unexpectedly Cuts Rate to 1% in Second Consecutive Easing Measure

A Look At Botanix Pharmaceuticals (ASX:BOT) Valuation After Its A$45m Follow On Equity Offerings

Simply Wall St.

Botanix Pharmaceuticals to Raise About AU$40 Million via Share Placement; Shares Hit Three-Year Low

MT Newswires Live

BRIEF-Botanix Pharmaceuticals Receives Firm Commitments For A$40 Million Two-Tranche Placement

Botanix Pharmaceuticals Ltd - Firm Commitments for a$40 Mln Two-Tranche Placement at a$0.06 per New Share

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BOT.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BOT.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BOT.AU\",,,,,undefined,":{"symbol":"BOT.AU","market":"AU","secType":"STK","nameCN":"BOTANIX PHARMACEUTICALS LTD","latestPrice":0.02,"timestamp":1782278845399,"preClose":0.02,"halted":0,"volume":25646655,"delay":0,"changeRate":0,"nameEN":"BOTANIX PHARMACEUTICALS LTD","floatShares":1717605114,"shares":2734312800,"eps":-0.046233,"marketStatus":"Trading","change":0,"latestTime":"06-24 15:31:50 AEST","open":0.019,"high":0.02,"low":0.018,"amount":491732,"amplitude":0.1,"askPrice":0.02,"askSize":4158314,"bidPrice":0.019,"bidSize":7723596,"shortable":3,"etf":0,"ttmEps":-0.046233,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1782280800000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.02,"openAndCloseTimeList":[[1782259200000,1782280800000]],"volumeRatio":2.206074,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"BOT.AU","preClose":0.02,"auctionPrice":0.019,"auctionVolume":2223408,"auctionTime":1782259143967,"referenceTime":1782212404120,"auction":1,"marketStatus":"盘前竞价","timestamp":1782259143967}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BOT.AU\",,,,,undefined,":{"symbol":"BOT.AU","floatShares":1717605114,"roa":"-53.38%","roe":"-121.11%","lyrEps":-0.046827,"volumeRatio":2.206074,"shares":2734312800,"dividePrice":0,"high":0.02,"amplitude":0.1,"preClose":0.02,"low":0.018,"week52Low":0.018,"pbRate":"1.01","psRate":"2.50","week52High":0.35,"institutionHeld":0,"latestPrice":0.02,"committee":0.30006,"eps":-0.046233,"divideRate":0,"volume":25646655,"delay":0,"ttmEps":-0.046233,"open":0.019,"prevYearClose":0.135,"prevWeekClose":0.022,"prevMonthClose":0.024,"prevQuarterClose":0.042,"fiveDayClose":0.023,"twentyDayClose":0.025,"sixtyDayClose":0.041},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BOT.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BOT.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BOT.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642267240","title":"Thailand's Foreign Reserves Rise in May","url":"https://stock-news.laohu8.com/highlight/detail?id=2642267240","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642267240?lang=en_us&edition=fundamental","pubTime":"2026-06-12 19:18","pubTimestamp":1781263124,"startTime":"0","endTime":"0","summary":"Thailand's international reserves rose at the end of May, quelling fears of a currency crisis.Foreign reserves rose to $287.5 billion in the week ended May 29, according to data released by the Bank o","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BOT.AU","BK7502","BK7508","BOT","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636968860","title":"BLUE OCEAN TECHNOLOGIES APPOINTS WILLIAM GOODBODY, JR. AS HEAD OF MARKET OPERATIONS FOR BLUE OCEAN ATS IN AUSTRALIA","url":"https://stock-news.laohu8.com/highlight/detail?id=2636968860","media":"prnewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636968860?lang=en_us&edition=fundamental","pubTime":"2026-05-20 06:35","pubTimestamp":1779230100,"startTime":"0","endTime":"0","summary":"Strategic Appointment Expands Blue Ocean Technologies' Presence Across the APAC Region. Bill brings more than 30 years of experience spanning global equities, foreign exchange, and digital assets across major financial centers in the United States, Europe, and APAC. Throughout his career, he has held senior leadership positions at globally recognized firms including Bats Global Markets, Hotspot FX, Knight Capital Group, AE Capital, and Zerocap.Brian Hyndman, CEO of Blue Ocean Technologies commented, \"Bill's deep operational expertise, institutional market knowledge, and extensive capital markets experience building and scaling global trading businesses make him an exceptional addition to the Blue Ocean ATS team. In his new role, Bill will focus on enhancing operational capabilities, supporting strategic partnerships, and accelerating Blue Ocean Technologies' growth initiatives throughout APAC. This appointment marks an important milestone in our international growth strategy as we cont","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/blue-ocean-technologies-appoints-william-goodbody-jr-as-head-of-market-operations-for-blue-ocean-ats-in-australia-302776886.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOT","BK7096","FOR","BOT.AU","BK4161","NMS","ATS","BK7508","BK7502","BK4024"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636713840","title":"Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2636713840","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636713840?lang=en_us&edition=fundamental","pubTime":"2026-05-18 21:56","pubTimestamp":1779112603,"startTime":"0","endTime":"0","summary":"May 18 (Reuters) - Piramal Pharma Ltd ::*PIRAMAL PHARMA SOLUTIONS ANNOUNCES PARTNERSHIP WITH BOTANIX TO SUPPORT DRUG SUBSTANCE DEVELOPMENT  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 18-MAY-202613:00:20.713 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nRSD2g7qhm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7502","BOT.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632981581","title":"Botanix Pharmaceuticals Appoints Chief Operating Officer; Shares Fall 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632981581","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632981581?lang=en_us&edition=fundamental","pubTime":"2026-05-04 08:39","pubTimestamp":1777855179,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals  has promoted Paul Seaback to chief operating officer, according to a Monday filing with the Australian bourse.Seaback joined the commercial dermatology company in November 2024 as chief technical officer.Shares of Botanix Pharmaceuticals fell 4% in recent Monday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BOT.AU","BK7508","BK7096","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632986013","title":"Botanix Pharmaceuticals Ltd - Appoints Paul Seaback as Chief Operating Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2632986013","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632986013?lang=en_us&edition=fundamental","pubTime":"2026-05-04 07:06","pubTimestamp":1777849587,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260503:nTUE9CPLQ6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7508","BOT.AU","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632860159","title":"Botanix Pharmaceuticals Ltd-Botanix Appoints Chief Operating Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2632860159","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632860159?lang=en_us&edition=fundamental","pubTime":"2026-05-04 07:06","pubTimestamp":1777849587,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260503:nTUE9CPLQ6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","BK7508","BOT.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632262692","title":"Botanix Pharmaceuticals' Q3 Results Beat Estimates, Says Euroz Hartleys","url":"https://stock-news.laohu8.com/highlight/detail?id=2632262692","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632262692?lang=en_us&edition=fundamental","pubTime":"2026-05-01 14:14","pubTimestamp":1777616044,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals  fiscal third quarter results beat Euroz Hartleys' estimates with the fifth consecutive quarter of prescription growth, according to a Thursday Euroz Hartleys note.Total prescriptions increased 5% quarter-on-quarter to 26,684, slightly above Euroz Hartleys' estimates of 26,500. and gross-to-net yield declined quarter-on-quarter from 24% to 18%, in line with the research firm's expectations.The company's current AU$60 million enterprise value does not fully reflect the AU$34.5 million of inventory held on the balance sheet, the research firm added.The research firm believes that Botanix's Sofdra has the makings of a category leader in hyperhidrosis, a dermatology condition, and added that consistent prescription growth alone, or the addition of a new product to its platform, can potentially re-rate the stock \"materially higher.\"Euroz Hartkeys has a buy rating on Botanix Pharmaceuticals with a price target of AU$0.25.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BOT.AU","BK7096","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631532087","title":"Botanix Pharmaceuticals Ltd-Botanix Q3 FY26 Investor Update Webinar Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2631532087","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631532087?lang=en_us&edition=fundamental","pubTime":"2026-04-29 06:54","pubTimestamp":1777416892,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nTUE41ZQWL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7502","BK7508","BOT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627260648","title":"BRIEF-Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier","url":"https://stock-news.laohu8.com/highlight/detail?id=2627260648","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627260648?lang=en_us&edition=fundamental","pubTime":"2026-04-16 16:03","pubTimestamp":1776326609,"startTime":"0","endTime":"0","summary":"BRIEF-Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API SupplierApril 16  - Botanix Pharmaceuticals Ltd BOT.AX:BOTANIX REACHES TERM SHEET AGREEMENT WITH SECOND API SUPPLIERPIRAMAL TO COMMENCE DEVELOPMENT SERVICES , SERVE AS ALTERNATE COMMERCIAL SUPPLIER OF SOFPIRONIUM BROMIDE, API IN SOFDRAFurther company coverage: BOT.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nFWN40Y0YC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7502","BOT.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627263405","title":"BUZZ-Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2627263405","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627263405?lang=en_us&edition=fundamental","pubTime":"2026-04-16 12:06","pubTimestamp":1776312376,"startTime":"0","endTime":"0","summary":"BUZZ-Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions** Shares of Australia's Botanix Pharmaceuticals BOT.AX surge as much as 22.2% to A$0.04, their highest level since July 9, 2025** Highest level since April 2** Dermatology co reaches term sheet agreement with PPL Pharma Solutions Riverview for manufacturing and supply arrangement** Under deal, PPL to start certain development services, serve as alternate commercial supplier of Sofpironium Bromide ** About 101.5 million shares change hands, 5.4 times the 30-day avg** Down 71.1% YTD, including the session's moves  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nL6N40Z0A7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BK7508","BK7502","BOT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627557552","title":"Botanix Pharmaceuticals - Piramal to Commence Development Services , Serve as Alternate Commercial Supplier of Sofpironium Bromide, API in Sofdra","url":"https://stock-news.laohu8.com/highlight/detail?id=2627557552","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627557552?lang=en_us&edition=fundamental","pubTime":"2026-04-16 06:51","pubTimestamp":1776293499,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40Y0YC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","BK7502","BOT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623536172","title":"Botanix Pharmaceuticals Defers API Purchases to 2027, 2028 Under Amended Supply Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2623536172","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623536172?lang=en_us&edition=fundamental","pubTime":"2026-03-30 09:15","pubTimestamp":1774833312,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals  said it has amended its active pharmaceutical ingredient  supply agreement with Kaken Pharmaceutical, rescheduling purchases to December 2027 and December 2028 from the previously set dates for April 2026 and January 2027, according to a Monday Australian bourse filing.The company said following a recent API purchase earlier this month, no further API purchases are required before December 2027, while activities continue to establish an alternate API supplier for Sofpironium Bromide with a view to de-risking the supply chain and achieving potential savings of 25% to 40% in cost of goods sold.Deferring the purchases, in conjunction with proceeds from the current capital raise if approved, is expected to strengthen Botanix's ability to pursue its plans for Sofdra and its fulfillment platform, the filing added.The company's shares fell 2% in recent Monday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7096","BK4535","OTX.SI","BK4503","BK6520","API.AU","BK6100","BK4551","BOT.AU","BK4023","API","BK7502","BK7103"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618398345","title":"Botanix Pharmaceuticals' Axillary Hyperhidrosis Product Outsells Competing Product, Says Euroz Hartleys","url":"https://stock-news.laohu8.com/highlight/detail?id=2618398345","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618398345?lang=en_us&edition=fundamental","pubTime":"2026-03-10 13:11","pubTimestamp":1773119492,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals'  axillary hyperhidrosis product, Sofdra, has exceeded the competing product Qbrexza in the week ending February 27, according to a Tuesday note by Euroz Hartleys.Euroz Hartleys said that an estimated 2,726 prescriptions of Sofdra were dispensed in the period, according to Symphony Health, which shows 15% week-on-week growth and the highest weekly prescription level on record.Given its role as corporate adviser, the research firm said it is restricted from providing a price target or rating at this time.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BOT.AU","BK7508","BK7096","BK7502"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2614072882","title":"BRIEF-Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614072882","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614072882?lang=en_us&edition=fundamental","pubTime":"2026-02-27 15:57","pubTimestamp":1772179062,"startTime":"0","endTime":"0","summary":"BRIEF-Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 MillionFeb 27 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX:HY LOSS ATTRIBUTABLE A$33.2 MILLIONREVENUE FROM ORDINARY ACTIVITIES FOR HY A$16.5 MILLIONFurther company coverage: BOT.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nFWN3ZM2A8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BK7508","BK7502","BOT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614000023","title":"Botanix Pharmaceuticals Ltd - Revenue From Ordinary Activities for Hy a$16.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2614000023","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614000023?lang=en_us&edition=fundamental","pubTime":"2026-02-27 12:21","pubTimestamp":1772166100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nFWN3ZM2A8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","BK7502","BOT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614388890","title":"Bank of Thailand Unexpectedly Cuts Rate to 1% in Second Consecutive Easing Measure","url":"https://stock-news.laohu8.com/highlight/detail?id=2614388890","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614388890?lang=en_us&edition=fundamental","pubTime":"2026-02-25 16:28","pubTimestamp":1772008080,"startTime":"0","endTime":"0","summary":"TradingKey - The Bank of Thailand (BOT) has lowered its policy rate to 1.00%, the lowest level since September 2022. This marks the institution's second consecutive easing measure aimed at supporting economic recovery and addressing the pain points of sluggish domestic growth and elevated deflationa","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230817/33178b9b092a09cb252a15334d0896f3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230817/33178b9b092a09cb252a15334d0896f3.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/economic-indicator/261618327-thailand-bot-interest-rates-thb-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BK7508","BK7502","BOT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612413214","title":"A Look At Botanix Pharmaceuticals (ASX:BOT) Valuation After Its A$45m Follow On Equity Offerings","url":"https://stock-news.laohu8.com/highlight/detail?id=2612413214","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612413214?lang=en_us&edition=fundamental","pubTime":"2026-02-18 12:44","pubTimestamp":1771389874,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals (ASX:BOT) has drawn fresh attention after filing multiple follow on equity offerings totaling A$45 million. The company is issuing new ordinary shares at A$0.06 with attached options that could reshape its capital structure.\nSee our latest analysis for Botanix Pharmaceuticals.\nThat equity raising lands after a sharp reset in sentiment, with a 1 day share price return showing a 41.33% decline at the latest A$0.066 close and a 1 year total shareholder return of 86.80%...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-bot/botanix-pharmaceuticals-shares/news/a-look-at-botanix-pharmaceuticals-asxbot-valuation-after-its","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-bot/botanix-pharmaceuticals-shares/news/a-look-at-botanix-pharmaceuticals-asxbot-valuation-after-its","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4585","EQR","BK4215","BK7502","BK7096","BOT.AU","DCF","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612436270","title":"Botanix Pharmaceuticals to Raise About AU$40 Million via Share Placement; Shares Hit Three-Year Low","url":"https://stock-news.laohu8.com/highlight/detail?id=2612436270","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612436270?lang=en_us&edition=fundamental","pubTime":"2026-02-17 10:37","pubTimestamp":1771295855,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals  received firm commitments to raise about  AU$40 million via a two-tranche placement of 666.7 million shares at AU$0.06 per share, according to a Tuesday filing with the Australian bourse.The offer price represents an 45.5% discount to the stock's last traded price before the trading halt on Feb.13, the filing said.Tranche one is expected to raise around AU$14.9 million by issuing 247.9 million shares at the offer price, while tranche two aims to raise about AU$25.1 million through the issue of 418.7 million shares, subject to shareholder approval, the filing added.The company will also allow eligible shareholders to participate in a share purchase plan to raise up to AU$5 million at the same price, the company said.Funds raised will be used towards the purchase of active pharmaceutical ingredient  and costs to obtain a second API supplier, the company added.The new shares are expected to settle in early April.Shares of the company fell 39% in recent Tuesday tra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["API","API.AU","BK4023","BK4535","BK7103","BK4503","BK7096","BOT.AU","BK7508","BK7502","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612403435","title":"BRIEF-Botanix Pharmaceuticals Receives Firm Commitments For A$40 Million Two-Tranche Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2612403435","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612403435?lang=en_us&edition=fundamental","pubTime":"2026-02-17 09:23","pubTimestamp":1771291417,"startTime":"0","endTime":"0","summary":"BRIEF-Botanix Pharmaceuticals Receives Firm Commitments For A$40 Million Two-Tranche Placement Feb 17 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX:FIRM COMMITMENTS FOR A$40 MILLION TWO-TRANCHE PLACEMENT AT A$0.06 PER NEW SHAREFurther company coverage: BOT.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nFWN3ZC0H5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BK7508","BOT.AU","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612438681","title":"Botanix Pharmaceuticals Ltd - Firm Commitments for a$40 Mln Two-Tranche Placement at a$0.06 per New Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2612438681","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612438681?lang=en_us&edition=fundamental","pubTime":"2026-02-17 06:43","pubTimestamp":1771281803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260216:nFWN3ZC0H5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BOT.AU","BK7096","BK7502"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":29,"code":"91000000","status":"200"}]}}